TaiMed Biologics taps on humanized mAb for HIV therapy

Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver inno...

March 14, 2012 | Wednesday | News
Aussie firm begins prostate cancer screening test in US

Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate canc...

April 8, 2014 | Tuesday | News
Cell death pioneer wins Agilent thought leader award

Singapore: Dr Junying Yuan, a pioneer and leading researcher in the field of cell death at the Chinese Academy of Scienc...

December 11, 2013 | Wednesday | Influencers
Samsung to make Roche biologics at Korean plant

Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsu...

October 24, 2013 | Thursday | News
Sanofi begins biopharmaceutical plant construction

Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...

January 30, 2014 | Thursday | News
Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug

‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...

April 24, 2014 | Thursday | News
Biologics' demand will boost cell culture, stem cell market

Singapore: Cell culture is going to become the next big pharmaceutical trend, as laboratories rush to meet demand for st...

November 14, 2012 | Wednesday | Analysis
Austrianova starts cell bank for cancer therapy

Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...

March 21, 2013 | Thursday | News
Genzyme to invest $80 mn to boost Fabrazyme production

Singapore: Genzyme, a Sanofi company, plans to invest USD80 million to build a new downstream processing facility for Fa...

October 17, 2013 | Thursday | News
Australian academy of science gets new council members

Singapore: Internationally-recognized experts in computing and atmospheric physics, developmental biology, organometalli...

November 21, 2012 | Wednesday | News
China marches ahead with regulatory approvals

After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) iss...

March 7, 2012 | Wednesday | News
Ranbaxy to market infliximab biosimilar

Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...

January 9, 2014 | Thursday | News
David Johnston to lead PPD's lab services

Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of globa...

August 9, 2013 | Friday | Influencers
Agilent, Korea institute to launch neurometabolomics center

Singapore: Agilent Technologies and Korea-based Daegu Gyeongbuk Institute of Science and Technology (DGIST) have collabo...

October 28, 2013 | Monday | News
Shire biologics facility gets FDA clearance

Singapore: Shire, global specialty biopharmaceutical company, has recieved US FDA approval for production of VPRIV drug ...

February 18, 2014 | Tuesday | News
MedImmune, UCSF enter 3-year R&D deal

Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...

February 18, 2014 | Tuesday | News
D A Prasanna is ACRO India's new Chairman

Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Pra...

January 16, 2014 | Thursday | News
India announces new biosimilar regulatory guidelines

Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been...

June 19, 2012 | Tuesday | Regulatory